Gain Therapeutics Inc. (GANX)
NASDAQ: GANX
· Real-Time Price · USD
1.68
-0.06 (-3.45%)
At close: Jun 17, 2025, 3:07 PM
Gain Therapeutics Revenue
Gain Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2025, Gain Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
23
Market Cap
50.31M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|